These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30261852)

  • 21. Predictors of multidrug resistant tuberculosis among adult patients at Saint Peter Hospital Addis Ababa, Ethiopia.
    Dessalegn M; Daniel E; Behailu S; Wagnew M; Nyagero J
    Pan Afr Med J; 2016; 25(Suppl 2):5. PubMed ID: 28439330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt.
    Gadallah MA; Mokhtar A; Rady M; El-Moghazy E; Fawzy M; Kandil SK
    J Formos Med Assoc; 2016 Nov; 115(11):997-1003. PubMed ID: 26696497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active surveillance for adverse events in patients on longer treatment regimens for multidrug-resistant tuberculosis in Viet Nam.
    Ngoc NB; Vu Dinh H; Thuy NT; Quang DV; Huyen CTT; Hoa NM; Anh NH; Dat PT; Hoa NB; Tiemersma E; Nhung NV
    PLoS One; 2021; 16(9):e0255357. PubMed ID: 34492031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcomes and associated factors among patients with multidrug-resistant tuberculosis in Ashanti Region, Ghana: a retrospective, cross-sectional study.
    Panford V; Kumah E; Kokuro C; Adoma PO; Baidoo MA; Fusheini A; Ankomah SE; Agyei SK; Agyei-Baffour P
    BMJ Open; 2022 Jul; 12(7):e062857. PubMed ID: 35790328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis.
    Schnippel K; Firnhaber C; Conradie F; Ndjeka N; Sinanovic E
    Appl Health Econ Health Policy; 2018 Feb; 16(1):43-54. PubMed ID: 28980217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug resistant tuberculosis treatment outcome in children in developing and developed countries: A systematic review and meta-analysis.
    Tola HH; Khadoura KJ; Jimma W; Nedjat S; Majdzadeh R
    Int J Infect Dis; 2020 Jul; 96():12-18. PubMed ID: 32289559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
    Yew WW
    Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes and adherence of shorter MDR TB regimen in patients with multidrug resistant tuberculosis.
    Kumari SL; Kongara S; Bhaskar K; Srikanti R; Bhushana Rao CRN; Sanjana PH
    Indian J Tuberc; 2023 Jan; 70(1):103-106. PubMed ID: 36740304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis.
    Ettehad D; Schaaf HS; Seddon JA; Cooke GS; Ford N
    Lancet Infect Dis; 2012 Jun; 12(6):449-56. PubMed ID: 22373593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis.
    Isaakidis P; Casas EC; Das M; Tseretopoulou X; Ntzani EE; Ford N
    Int J Tuberc Lung Dis; 2015 Aug; 19(8):969-78. PubMed ID: 26162364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low enrollment and high treatment success in children with drug-resistant tuberculosis in Ethiopia: A ten years national retrospective cohort study.
    Tola HH; Holakouie-Naieni K; Mansournia MA; Yaseri M; Tesfaye E; Mahamed Z; Molla Sisay M
    PLoS One; 2020; 15(2):e0229284. PubMed ID: 32101580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline Predictors of Treatment Outcomes in Children With Multidrug-Resistant Tuberculosis: A Retrospective Cohort Study.
    Chiang SS; Starke JR; Miller AC; Cruz AT; Del Castillo H; Valdivia WJ; Tunque G; García F; Contreras C; Lecca L; Alarcón VA; Becerra MC
    Clin Infect Dis; 2016 Oct; 63(8):1063-71. PubMed ID: 27458026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients.
    Pawar UM; Kundnani V; Agashe V; Nene A; Nene A
    Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of Pakistan.
    Khan I; Ahmad N; Khan S; Muhammad S; Ahmad Khan S; Ahmad I; Khan A; Gulalai ; Atif M
    J Infect Public Health; 2019; 12(6):809-815. PubMed ID: 31056438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment outcomes of patients with MDR-TB in Nepal on a current programmatic standardised regimen: retrospective single-centre study.
    Ghimire S; Karki S; Maharjan B; Kosterink JGW; Touw DJ; van der Werf TS; Shrestha B; Alffenaar JW
    BMJ Open Respir Res; 2020 Aug; 7(1):. PubMed ID: 32796020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance.
    Ahmad N; Javaid A; Basit A; Afridi AK; Khan MA; Ahmad I; Sulaiman SA; Khan AH
    Int J Tuberc Lung Dis; 2015 Sep; 19(9):1109-14, i-ii. PubMed ID: 26260834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
    Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study.
    Javaid A; Ullah I; Masud H; Basit A; Ahmad W; Butt ZA; Qasim M
    Clin Microbiol Infect; 2018 Jun; 24(6):612-617. PubMed ID: 28970158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002-2006.
    Masjedi MR; Tabarsi P; Chitsaz E; Baghaei P; Mirsaeidi M; Amiri MV; Farnia P; Javanmard P; Mansouri D; Velayati AA
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):750-5. PubMed ID: 18544199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.